期刊文献+

定量检测子痫前期孕妇血浆中超甲基化的RASSF1A基因 被引量:3

Quantitative detection of the hypermethylated RASSF1A gene in maternal plasma of pre-eclampsia
原文传递
导出
摘要 目的探讨子痫前期孕妇血浆中超甲基化的Ras相关区域家族1A(ras association domain family 1A,RASSF1A)基因的水平变化及应用价值。方法选择晚期妊娠子痫前期患者60例为实验组,其中轻度和重度子痫前期各30例;正常晚期孕妇60名为对照组。提取血浆游离DNA,经甲基化敏感的限制性内切酶处理,实时定量检测酶切前、后RASSF1A基因的浓度,同时检测β肌动蛋白(β-actin)基因以确保酶的完全消化。结果子痫前期孕妇血浆中超甲基化的RASSF1A基因含量为正常妊娠组的3.31倍。轻、重度子痫前期患者浓度有差异,中位数分别为1659.00copies/mL及2036.50copies/mL(P〈0.05)。结论子痫前期孕妇血浆中的超甲基化RASSF1A基因含量明显升高,且浓度水平与子痫前期的严重程度相关。 Objective To investigate the level of hypermethylated ras association domain family 1A (RASSF1A)gene in maternal plasma of pre-eclampsia and its clinical value. Methods Sixty pre-eclampsia women including 30 mild and 30 severe cases were selected, 60 women with normal pregnancy were studied as control. Free DNA from plasma samples was extracted, fluorescence quantitative polymerase chain reaction (FQ PCR) was used to detect the concentrations of RASSF1A gene before and after methylationsensitive restriction digestion. Meanwhile, β-actin gene was detected as a control to confirm complete enzyme digestion. Results The median concentration of hypermethylated RASSF1A gene was 3. 31-fold higher in samples from pre-eclamptic pregnancies than that in controls. There was significant difference between the mild and severe pre-eclamptic subjects (P〈0. 05), with the median concentrations of 1659 copies/mL and 2036. 50 copies/mL, respectively. Conclusion Hypermethylated RASSF1A gene in preeclampsia plasma was significantly increased and the concentrations were related to the severity of preeclampsia.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2010年第1期73-76,共4页 Chinese Journal of Medical Genetics
基金 国家人口计生委资助项目(200511号C1-41) 山西省科技厅攻关项目(20080311072)
关键词 孕妇血浆 超甲基化RASSF1A基因 子痫前期 定量检测 maternal plasma hypermethylated RASSFIA gene pre-eclampsia quantitative detection
  • 相关文献

参考文献6

  • 1Sekizawa A, Farina A, Sugito Y, et al. Proteinuria and hypertension are independent factors affecting fetal DNA values: a retrospective analysis of affected and unaffected patients. Clin Chem, 2004, 50: 221-224.
  • 2Chan KCA, Ding C, Gerovassili A, et al. Hypermethylated RASSFIA in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem, 2006, 52: 2211-2218.
  • 3Chim SSC, Tong YK, Chiu RWK, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A, 2005, 102: 14753-14758.
  • 4Chiu RWK, Chim SSC, Wong IHN, et al. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol, 2007, 170:941-950.
  • 5Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, et al. Trophoblastic oxidative stress and the release of cell-free feto- placental DNA. Am J Pathol, 2006, 169:400-404.
  • 6Tsui DWY, Chan KCA, Chim SSC, et al. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre eelampsia. Prenat Diagn, 2007, 27:1212- 1218.

同被引文献39

  • 1Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet, 1997, 350 : 485-487.
  • 2Litton C, Stone J, Eddleman K, et al. Noninvasive prenatal diagnosis: past, present, and future. Mt Sinai J Med, 2009, 76: 521-528.
  • 3Hahn S, Holzgreve W. Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia. HumReprod Update, 2002, 8: 501-508.
  • 4Schmidt M, Hoffmann B, Beelen D, et al. Detection of circulating trophoblast particles in peripheral maternal blood in preeclampsia complicated pregnancies. Hypertens Pregnancy, 2008, 27 : 131-142.
  • 5Zhang L, Wang Y, Liao AH. Quantitative abnormalities of fetal trophoblast cells in maternal circulation in preeclampsia. Prenat Diagn,2008, 28:1160-1166.
  • 6Hahn S, Huppertz B, Holzgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta, 2005, 26:515-526.
  • 7Orozco AF, Jorgez CJ, Ramos-Perez WD, et al. Placental release of distinct DNA-associated micro-particles into maternal circulation: reflective of gestation time and preeclampsia. Placenta, 2009, 30:891-897.
  • 8Lazar L, Rig6 J Jr, Nagy B, et al. Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Medical Genetics, 2009, 10 : 120.
  • 9Vlkovd B, Szemes T, Mindrik G, et al. Circulating free fetal nucleic acids in maternal plasma and preeclampsia. Med Hypotheses, 2010,74 : 1030-1032.
  • 10Purwosunu Y, Sekizawa A, Koide K, et al. Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue- type plasminogen activator are increased in the plasma of pregnant women with preeclampsia. Clin Chem, 2007, 53: 399-404.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部